Actually, DADS treatment accelerated the decrease in the relative levels of PO2F1 protein in CRC cells in the presence of protein synthesis inhibitor CHX (cycloheximide) (Figure 5B), suggesting that DADS treatment might promote the degradation of POU2F1 protein in CRC cells. This evidence concerns the gene POU2F1 and colorectal carcinoma.